Atherosclerosis: current pathogenesis and therapeutic optionsChristian Weber(Ludwig-Maximilians-Universität München), Heidi Noels(RWTH Aachen University)Nature MedicineNovember 1, 201110.1038/nm.2538Cited by 2,188SaveCiteExport RISWatch citationsAbstractRelated PapersNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsPeter Duewell, Hajime Kono, Katey J. Rayner et al.|Nature|2010|3.9kPioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.A. Michael Lincoff, Kathy Wolski, Stephen J. Nicholls et al.|PubMed|2007|1.3kMacrophage death and defective inflammation resolution in atherosclerosisIra Tabas|Nature reviews. Immunology|2009|1.1kMonocytes in atherosclerosis: subsets and functionsKevin Woollard, Frédéric Geissmann|Nature Reviews Cardiology|2010|886ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell ProliferationLaurent Yvan‐Charvet, Tamara A. Pagler, Emmanuel L. Gautier et al.|Science|2010|711